I can feel our collective impatience on awaiting some sort of...

I can feel our collective impatience on awaiting some sort of feedback from the trial results for the 1b.

I want to know how they have gone in their check up phase and I hope they are all still with us.

The hope is we receive the follow up results before the start of Phase 2 . I would imagine Phase 2 commencement will be contingent on receiving optimistic news from the Phase1b  check ups.

As an investor I just want to know what's happening. However, in some weird way I am happy IMU is ignoring my impatience and just concentrating on the science! That's what will make IMU successful in the end. I am sure they will tell us when they know.

Its like being a father in the waiting room waiting for your first born baby!

I have no doubt big Pharma is looking very closely at IMU and if they see any hint of  success through the Phase 2 trial they will pounce. The 1b was just too small to be scientifically significant.

Good luck to all holders!